歌礼制药-B(01672)于2026年7月7日公告，公司当日在香港联交所场内回购股份10万股，占公司已发行股本约0.0094%。每股回购价介乎11.28港元至11.67港元，总耗资约115.32万港元。
公司已通过2026年6月29日的股东大会决议获得回购授权，授权回购股份总数为106137084股。自通过授权以来，公司累计回购股份245000股，占决议通过当日已发行股本约0.0231%。是次回购后，公司已发行股本仍为1061370845股，库藏股为7084210股。
公司确认已遵守香港联交所证券上市规则及相关法规规定。本公告由公司秘书钟明辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.